News of Note—Novavax, Walter Reed and more


Here is some other vaccine news of note for the week:

> Novavax has enrolled the first participants in a phase 2 study of its NanoFlu in older adults. Release

> The Walter Reed Army Institute of Research signed a deal with Enesi Pharma for the development of a needle-free Shigella vaccine. Release

> The Biomedical Advanced Research and Development Authority awarded Altimmune an additional $2.5 million to support work on its anthrax vaccine candidate NasoShield. Release

> LineaRx, a subsidiary of Applied DNA, signed on with Takis and Evvivax to developed DNA-based cancer vaccines. Release


Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.